These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28379880)
1. Immunoresponsive Autonomic Neuropathy in Sjögren Syndrome-Case Series and Literature Review. Goodman BP Am J Ther; 2019; 26(1):e66-e71. PubMed ID: 28379880 [TBL] [Abstract][Full Text] [Related]
2. Sjögren Sensory Neuronopathy (Sjögren Ganglionopathy): Long-Term Outcome and Treatment Response in a Series of 13 Cases. Pereira PR; Viala K; Maisonobe T; Haroche J; Mathian A; Hié M; Amoura Z; Cohen Aubart F Medicine (Baltimore); 2016 May; 95(19):e3632. PubMed ID: 27175675 [TBL] [Abstract][Full Text] [Related]
3. Spectrum of Autonomic Nervous System Impairment in Sjögren Syndrome. Goodman BP; Crepeau A; Dhawan PS; Khoury JA; Harris LA Neurologist; 2017 Jul; 22(4):127-130. PubMed ID: 28644253 [TBL] [Abstract][Full Text] [Related]
4. Isolated autonomic cardiovascular neuropathy in a patient with primary Sjögren syndrome: a case of successful treatment with glucocorticoid. Shimoyama M; Ohtahara A; Okamura T; Watanabe M; Fujimoto Y; Teshima S; Takeda S; Hisatome I; Shigamasa C Am J Med Sci; 2002 Sep; 324(3):170-2. PubMed ID: 12240717 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment for peripheral neuropathies in Sjogren's syndrome - a systematic review. Humă AC; Kecskeş EM; Tulbă D; Bălănescu P; Băicuş C Rom J Intern Med; 2020 Mar; 58(1):5-12. PubMed ID: 31527298 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy Provides Electrophysiological Recovery and Excellent Clinical Response in Sjogren's Syndrome-Linked Quite Severe Autonomic Neuropathy. Sokmen O; Temucin CM; Ayhan Seker C; Tan E Neurologist; 2023 May; 28(3):204-206. PubMed ID: 36223306 [TBL] [Abstract][Full Text] [Related]
7. Immunoresponsive postinfectious autonomic neuropathy. Goodman BP Am J Ther; 2014; 21(4):e120-3. PubMed ID: 23942134 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome. Choung BS; Yoo WH Rheumatol Int; 2012 May; 32(5):1353-5. PubMed ID: 20237930 [TBL] [Abstract][Full Text] [Related]
10. Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Mukaino A; Nakane S; Higuchi O; Nakamura H; Miyagi T; Shiroma K; Tokashiki T; Fuseya Y; Ochi K; Umeda M; Nakazato T; Akioka S; Maruoka H; Hayashi M; Igarashi S; Yokoi K; Maeda Y; Sakai W; Matsuo H; Kawakami A Mod Rheumatol; 2016 Sep; 26(5):708-15. PubMed ID: 26873295 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Flanagan EP; Saito YA; Lennon VA; McKeon A; Fealey RD; Szarka LA; Murray JA; Foxx-Orenstein AE; Fox JC; Pittock SJ Neurogastroenterol Motil; 2014 Sep; 26(9):1285-97. PubMed ID: 25039328 [TBL] [Abstract][Full Text] [Related]
12. Does autonomic nervous impairment have a role in pathophysiology of Sjögren's syndrome. Hakala M; Niemelä RK Lancet; 2000 Mar; 355(9209):1032-3. PubMed ID: 10744085 [No Abstract] [Full Text] [Related]
13. Novel Sjögren's autoantibodies found in fibromyalgia patients with sicca and/or xerostomia. Applbaum E; Lichtbroun A Autoimmun Rev; 2019 Feb; 18(2):199-202. PubMed ID: 30572137 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Iodice V; Kimpinski K; Vernino S; Sandroni P; Fealey RD; Low PA Neurology; 2009 Jun; 72(23):2002-8. PubMed ID: 19506222 [TBL] [Abstract][Full Text] [Related]
15. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndrome. Verstappen GM; Moerman RV; van Nimwegen JF; van Ginkel MS; Bijzet J; Mossel E; Vissink A; Hazenberg BPC; Arends S; Kroese FGM; Bootsma H Rheumatology (Oxford); 2018 Oct; 57(10):1812-1821. PubMed ID: 29982712 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Waterman SA; Gordon TP; Rischmueller M Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771 [TBL] [Abstract][Full Text] [Related]
17. Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review. Bouxin M; Schvartz B; Mestrallet S; Debrumetz A; Hentzien M; Tabary T; Cohen R; Nicolas G; Bani-Sadr F J Neuroimmunol; 2019 Jan; 326():28-32. PubMed ID: 30468952 [TBL] [Abstract][Full Text] [Related]
18. From Molecular Mechanism to the Etiology of Sjogren Syndrome. Wei W; Ahmad SS; Chi S; Xie Y; Kamal MA; Li J Curr Pharm Des; 2018; 24(35):4177-4185. PubMed ID: 30332943 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal and Hepatic Disease in Sjogren Syndrome. Popov Y; Salomon-Escoto K Rheum Dis Clin North Am; 2018 Feb; 44(1):143-151. PubMed ID: 29149922 [TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome. Controversies and progress. Fox RI Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]